BRAF and melanoma: YUGEN8, a BRAF-mutated (V600E) and PTEN-null, short-term culture, established from a patient with BrM was subjected to in vivo and in vitro selection, and yielded several clonally related melanoma cell line variants with low or high brain-metastatic potential (Fig. 1A).